In one round of post-market surveillance, looking solely at antimalarials, substandard or counterfeit versions of 13 medicines were found at multiple locations. These were in use at a government-run hospital and private clinic, as well as being distributed through pharmacies.
“The existence of many more substandard and counterfeit medications for other types of medicines and in other locations and facilities must be assumed”, said Patrick Lukulay, director of the Promoting the Quality of Medicines initiative at the US Pharmacopeia (USP).